REPORT ID 8200

EMEA (Europe, Middle East and Africa) Central Nervous System Biomarkers Market Report 2017

Publish Date
7-Nov-17
Pages
109
Format
Electronic (PDF)

In this report, the EMEA Central Nervous System Biomarkers market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Central Nervous System Biomarkers for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Central Nervous System Biomarkers market competition by top manufacturers/players, with Central Nervous System Biomarkers sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Thermo Fisher Scientific
    Merck & Co
    AbaStar MDx Inc
    Abiant, Inc
    Avacta Group Plc
    Diagenic Asa
    Banyan Biomarkers
    Avid Radiopharmaceuticals Inc

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Safety Biomarker
    Efficacy Biomarker
    Validation Biomarker
    Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospitals
    Clinics
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Central Nervous System Biomarkers Market Report 2017
1 Central Nervous System Biomarkers Overview
    1.1 Product Overview and Scope of Central Nervous System Biomarkers
    1.2 Classification of Central Nervous System Biomarkers
        1.2.1 EMEA Central Nervous System Biomarkers Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Central Nervous System Biomarkers Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Safety Biomarker
        1.2.4 Efficacy Biomarker
        1.2.5 Validation Biomarker
        1.2.6 Other
    1.3 EMEA Central Nervous System Biomarkers Market by Application/End Users
        1.3.1 EMEA Central Nervous System Biomarkers Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Other
    1.4 EMEA Central Nervous System Biomarkers Market by Region
        1.4.1 EMEA Central Nervous System Biomarkers Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Central Nervous System Biomarkers (2012-2022)
        1.5.1 EMEA Central Nervous System Biomarkers Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Central Nervous System Biomarkers Revenue and Growth Rate (2012-2022)

2 EMEA Central Nervous System Biomarkers Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Central Nervous System Biomarkers Market Competition by Players/Manufacturers
        2.1.1 EMEA Central Nervous System Biomarkers Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Central Nervous System Biomarkers Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Central Nervous System Biomarkers Sale Price by Players (2012-2017)
    2.2 EMEA Central Nervous System Biomarkers (Volume and Value) by Type/Product Category
        2.2.1 EMEA Central Nervous System Biomarkers Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Central Nervous System Biomarkers Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Central Nervous System Biomarkers Sale Price by Type (2012-2017)
    2.3 EMEA Central Nervous System Biomarkers (Volume) by Application
    2.4 EMEA Central Nervous System Biomarkers (Volume and Value) by Region
        2.4.1 EMEA Central Nervous System Biomarkers Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Central Nervous System Biomarkers Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Central Nervous System Biomarkers Sales Price by Region (2012-2017)

3 Europe Central Nervous System Biomarkers (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Central Nervous System Biomarkers Sales and Value (2012-2017)
        3.1.1 Europe Central Nervous System Biomarkers Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Central Nervous System Biomarkers Revenue and Growth Rate (2012-2017)
    3.2 Europe Central Nervous System Biomarkers Sales and Market Share by Type
    3.3 Europe Central Nervous System Biomarkers Sales and Market Share by Application
    3.4 Europe Central Nervous System Biomarkers Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Central Nervous System Biomarkers Sales Volume by Countries (2012-2017)
        3.4.2 Europe Central Nervous System Biomarkers Revenue by Countries (2012-2017)
        3.4.3 Germany Central Nervous System Biomarkers Sales and Growth Rate (2012-2017)
        3.4.4 France Central Nervous System Biomarkers Sales and Growth Rate (2012-2017)
        3.4.5 UK Central Nervous System Biomarkers Sales and Growth Rate (2012-2017)
        3.4.6 Russia Central Nervous System Biomarkers Sales and Growth Rate (2012-2017)
        3.4.7 Italy Central Nervous System Biomarkers Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Central Nervous System Biomarkers Sales and Growth Rate (2012-2017)

4 Middle East Central Nervous System Biomarkers (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Central Nervous System Biomarkers Sales and Value (2012-2017)
        4.1.1 Middle East Central Nervous System Biomarkers Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Central Nervous System Biomarkers Revenue and Growth Rate (2012-2017)
    4.2 Middle East Central Nervous System Biomarkers Sales and Market Share by Type
    4.3 Middle East Central Nervous System Biomarkers Sales and Market Share by Application
    4.4 Middle East Central Nervous System Biomarkers Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Central Nervous System Biomarkers Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Central Nervous System Biomarkers Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Central Nervous System Biomarkers Sales and Growth Rate (2012-2017)
        4.4.4 Israel Central Nervous System Biomarkers Sales and Growth Rate (2012-2017)
        4.4.5 UAE Central Nervous System Biomarkers Sales and Growth Rate (2012-2017)
        4.4.6 Iran Central Nervous System Biomarkers Sales and Growth Rate (2012-2017)

5 Africa Central Nervous System Biomarkers (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Central Nervous System Biomarkers Sales and Value (2012-2017)
        5.1.1 Africa Central Nervous System Biomarkers Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Central Nervous System Biomarkers Revenue and Growth Rate (2012-2017)
    5.2 Africa Central Nervous System Biomarkers Sales and Market Share by Type
    5.3 Africa Central Nervous System Biomarkers Sales and Market Share by Application
    5.4 Africa Central Nervous System Biomarkers Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Central Nervous System Biomarkers Sales Volume by Countries (2012-2017)
        5.4.2 Africa Central Nervous System Biomarkers Revenue by Countries (2012-2017)
        5.4.3 South Africa Central Nervous System Biomarkers Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Central Nervous System Biomarkers Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Central Nervous System Biomarkers Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Central Nervous System Biomarkers Sales and Growth Rate (2012-2017)

6 EMEA Central Nervous System Biomarkers Manufacturers/Players Profiles and Sales Data
    6.1 Thermo Fisher Scientific
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Central Nervous System Biomarkers Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Thermo Fisher Scientific Central Nervous System Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Merck & Co
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Central Nervous System Biomarkers Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Merck & Co Central Nervous System Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 AbaStar MDx Inc
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Central Nervous System Biomarkers Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 AbaStar MDx Inc Central Nervous System Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Abiant, Inc
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Central Nervous System Biomarkers Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Abiant, Inc Central Nervous System Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Avacta Group Plc
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Central Nervous System Biomarkers Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Avacta Group Plc Central Nervous System Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Diagenic Asa
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Central Nervous System Biomarkers Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Diagenic Asa Central Nervous System Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Banyan Biomarkers
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Central Nervous System Biomarkers Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Banyan Biomarkers Central Nervous System Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Avid Radiopharmaceuticals Inc
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Central Nervous System Biomarkers Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Avid Radiopharmaceuticals Inc Central Nervous System Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview

7 Central Nervous System Biomarkers Manufacturing Cost Analysis
    7.1 Central Nervous System Biomarkers Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Central Nervous System Biomarkers

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Central Nervous System Biomarkers Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Central Nervous System Biomarkers Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Central Nervous System Biomarkers Market Forecast (2017-2022)
    11.1 EMEA Central Nervous System Biomarkers Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Central Nervous System Biomarkers Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Central Nervous System Biomarkers Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Central Nervous System Biomarkers Price and Trend Forecast (2017-2022)
    11.2 EMEA Central Nervous System Biomarkers Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Central Nervous System Biomarkers Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Central Nervous System Biomarkers Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Central Nervous System Biomarkers Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Central Nervous System Biomarkers Sales Forecast by Type (2017-2022)
    11.7 EMEA Central Nervous System Biomarkers Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer